Concurrent mental health therapy among medicaid-enrolled youths starting antipsychotic medications

Psychiatric Services

Volumn 63, Issue 4, 2012, Pages 351-356

  Harris, Emily ^a   Sorbero, Mark ^b   Kogan, Jane N ^a,b   Schuster, James ^b   Stein, Bradley D ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b and Outcomes   (United States)

^c RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; FEMALE; HOSPITALIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAID; MENTAL HEALTH; MINORITY GROUP; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRESCHOOL CHILD; PSYCHOSOCIAL CARE; SCHIZOPHRENIA; SCHOOL CHILD; URBAN POPULATION;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD; COMBINED MODALITY THERAPY; DRUG UTILIZATION; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICAID; MENTAL DISORDERS; MULTIVARIATE ANALYSIS; OFF-LABEL USE; PSYCHOTIC DISORDERS; RURAL POPULATION; SOCIOECONOMIC FACTORS; UNITED STATES; URBAN POPULATION;

EID: 84859818586     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201100329     Document Type: Article

References (42)

1. Pappadopulos E, Jensen PS, Schur SB, et al: "Real world" atypical antipsychotic prescribing practices in public child and adolescent inpatient settings. Schizophrenia Bulletin 28:111-121, 2002 (Pubitemid 34534755)
2. Cooper WO, Arbogast PG, Ding H, et al: Trends in prescribing of antipsychotic medications for US children. Ambulatory Pediatrics 6:79-83, 2006 (Pubitemid 43960577)
3. Olfson M, Blanco C, Liu L, et al: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry 63: 679-685, 2006 (Pubitemid 43848299)
4. Domino ME, Swartz MS: Who are the new users of antipsychotic medications? Psychiatric Services 59:507-514, 2008
5. Olfson M, Marcus SC, Weissman MM, et al: National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry 41:514-521, 2002 (Pubitemid 38338129)
6. Aparasu RR, Bhatara V: Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004. Current Medical Research and Opinion 23: 49-56, 2007 (Pubitemid 46191669)
7. Constantine R, Tandon R: Changing trends in pediatric antipsychotic use in Florida's Medicaid program. Psychiatric Services 59:1162-1168, 2008
8. Pathak P, West D, Martin BC, et al: Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005. Psychiatric Services 61:123-129, 2010
9. Constantine RJ, Tandon R, McPherson M, et al: Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's Medicaid program. Journal of Child and Adolescent Psychopharmacology 21: 79-84, 2011
10. DRUGDEX System. Greenwood Village, Colo, Thomson Reuters, 2008
11. Wolraich ML: Annotation: The use of psychotropic medications in children: an American view. Journal of Child Psychology and Psychiatry 44:159-168, 2003
12. Patel NC, Crismon ML, Hoagwood K, et al: Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program. Medical Care 44:87-90, 2006 (Pubitemid 43755484)
13. Thomas CP, Conrad P, Casler R, et al: Trends in the use of psychotropic medications among adolescents, 1994 to 2001. Psychiatric Services 57:63-69, 2006 (Pubitemid 43053838)
14. Findling RL: Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. Journal of Clinical Psychiatry 69(suppl 4):9-14, 2008
15. Brent DA, Holder D, Kolko D, et al: A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry 54:877-885, 1997 (Pubitemid 27383316)
16. Mufson L, Dorta KP, Wickramaratne P, et al: A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry 61:577-584, 2004 (Pubitemid 38747312)
17. Sonuga-Barke EJ, Daley D, Thompson M, et al: Parent-based therapies for preschool attention-deficit hyperactivity disorder: a randomized, controlled trial with a community sample. Journal of the American Academy of Child and Adolescent Psychiatry 40:402-408, 2001 (Pubitemid 32242523)
18. Wells KC, Epstein JN, Hinshaw SP, et al: Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. Journal of Abnormal Child Psychology 28:543-553, 2000
19. Abramowitz AJ, Eckstrand D, O'Leary SG, et al: ADHD children's responses to stimulant medication and two intensities of a behavioral intervention. Behavior Modification 16:193-203, 1992
20. McIntyre RS, Jerrell JM: Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. Archives of Pediatrics and Adolescent Medicine 162:929-935, 2008
21. Correll CU, Carlson HE: Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 45:771-791, 2006
22. Harris G: Use of antipsychotics in children is criticized. New York Times, Nov 18, 2008
23. Szalavitz M: Drugging the vulnerable: atypical antipsychotics in children and the elderly. Time Magazine, May 26, 2011. Available at www.topics.time.com/ addiction/articles/10/
24. Olfson M, Crystal S, Huang C, et al: Trends in antipsychotic drug use by very young, privately insured children. Journal of the American Academy of Child and Adolescent Psychiatry 49:13-23, 2010
25. Zito JM, Safer DJ, Zuckerman IH, et al: Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services 56:157-163, 2005 (Pubitemid 40216770)
26. Lurie N, Popkin M, Dysken M, et al: Accuracy of diagnoses of schizophrenia in Medicaid claims. Hospital and Community Psychiatry 43:69-71, 1992
27. Stein BD, Kogan JN, Sorbero M: Substance abuse detoxification and residential treatment among Medicaid-enrolled adults: rates and duration of subsequent treatment. Drug and Alcohol Dependence 104: 100-106, 2009
28. Stein BD, Kogan JN, Sorbero MJ, et al: Predictors of timely follow-up care among Medicaid-enrolled adults after psychiatric hospitalization. Psychiatric Services 58: 1563-1569, 2007
29. Patel NC, Sanchez RJ, Johnsrud MT, et al: Trends in antipsychotic use in a Texas Medicaid population of children and adolescents: 1996 to 2000. Journal of Child and Adolescent Psychopharmacology 12: 221-229, 2002 (Pubitemid 35191348)
30. Rani F, Murray ML, Byrne PJ, et al: Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 121:1002-1009, 2008
31. Crystal S, Olfson M, Huang C, et al: Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Affairs 28:w770-w781, 2009
32. Steiner H, Remsing L: Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. Journal of the American Academy of Child and Adolescent Psychiatry 46:126-141, 2007
33. Rosen D: A Clinical Guide for Pediatricians: Management of Mental Illness in Primary Care Practice: Part 2. Elk Grove Village, Ill, American Academy of Pediatrics, 2005
34. Jensen PS: The role of psychosocial therapies in managing aggression in children and adolescents. Journal of Clinical Psychiatry 69(suppl 4):37-42, 2008
35. American Academy of Pediatrics Subcommittee on Attention-Deficit/ Hyperactivity Disorder and Committee on Quality Improvement: Clinical practice guideline: treatment of the school-aged child with attention-deficit/ hyperactivity disorder. Pediatrics 108:1033-1044, 2001
36. Bernstein GA, Kinlan J: Summary of the practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry 36:1639-1641, 1997 (Pubitemid 27461114)
37. Pliszka S: Practice parameter for the assessment and treatment of children and adolescents with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 46:894-921, 2007
38. Gracious BL, Findling RL: Antipsychotic medications for children and adolescents. Pediatric Annals 30:138-145, 2001
39. Frazier TW, Youngstrom EA, Haycook T, et al: Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder. Journal of Child and Adolescent Psychopharmacology 20: 167-177, 2010
40. Meredith LS, Stein BD, Paddock SM, et al: Perceived barriers to treatment for adolescent depression. Medical Care 47:677-685, 2009
41. Leslie LK, Weckerly J, Landsverk J, et al: Racial-ethnic differences in the use of psychotropic medication in high-risk children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 42:1433-1442, 2003 (Pubitemid 39585973)
42. Cooper LA, Gonzales JJ, Gallo JJ, et al: The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Medical Care 41:479-489, 2003